Nautilus Free Cash Flow vs Depreciation Analysis

NAUT Stock  USD 2.11  0.06  2.76%   
Nautilus Biotechnology financial indicator trend analysis is infinitely more than just investigating Nautilus Biotechnology recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nautilus Biotechnology is a good investment. Please check the relationship between Nautilus Biotechnology Free Cash Flow and its Depreciation accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nautilus Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For more information on how to buy Nautilus Stock please use our How to Invest in Nautilus Biotechnology guide.

Free Cash Flow vs Depreciation

Free Cash Flow vs Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nautilus Biotechnology Free Cash Flow account and Depreciation. At this time, the significance of the direction appears to have strong relationship.
The correlation between Nautilus Biotechnology's Free Cash Flow and Depreciation is 0.72. Overlapping area represents the amount of variation of Free Cash Flow that can explain the historical movement of Depreciation in the same time period over historical financial statements of Nautilus Biotechnology, assuming nothing else is changed. The correlation between historical values of Nautilus Biotechnology's Free Cash Flow and Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow of Nautilus Biotechnology are associated (or correlated) with its Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation has no effect on the direction of Free Cash Flow i.e., Nautilus Biotechnology's Free Cash Flow and Depreciation go up and down completely randomly.

Correlation Coefficient

0.72
Relationship DirectionPositive 
Relationship StrengthSignificant

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Depreciation

Depreciation indicates how much of Nautilus Biotechnology value has been used up. For tax purposes Nautilus Biotechnology can deduct the cost of the tangible assets it purchases as business expenses. However, Nautilus Biotechnology must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.
Most indicators from Nautilus Biotechnology's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nautilus Biotechnology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nautilus Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For more information on how to buy Nautilus Stock please use our How to Invest in Nautilus Biotechnology guide.Selling General Administrative is likely to drop to about 25.5 M in 2024. Enterprise Value Over EBITDA is likely to drop to -5.49 in 2024
 2021 2022 2023 2024 (projected)
Reconciled Depreciation2.8M3.4M5.0M3.8M
Cost Of Revenue2.8M3.4M5.7M3.9M

Nautilus Biotechnology fundamental ratios Correlations

-0.280.710.790.94-0.71-0.70.790.18-0.44-0.260.85-0.44-0.40.440.92-0.450.870.890.870.890.890.690.840.35-0.31
-0.280.040.050.060.8-0.1-0.02-0.63-0.48-0.110.02-0.480.920.480.02-0.690.040.070.050.030.03-0.010.05-0.05-0.08
0.710.040.70.78-0.56-0.470.96-0.43-0.720.280.7-0.720.140.720.73-0.610.90.740.650.730.750.790.60.590.0
0.790.050.70.89-0.36-0.920.63-0.2-0.810.090.98-0.810.050.810.95-0.730.860.960.910.980.950.920.920.74-0.51
0.940.060.780.89-0.46-0.80.82-0.08-0.69-0.220.93-0.69-0.060.690.98-0.730.940.980.940.960.960.780.910.44-0.37
-0.710.8-0.56-0.36-0.460.2-0.62-0.32-0.01-0.11-0.4-0.010.720.01-0.44-0.19-0.52-0.4-0.39-0.42-0.45-0.44-0.34-0.29-0.05
-0.7-0.1-0.47-0.92-0.80.2-0.410.120.760.05-0.910.76-0.02-0.76-0.870.71-0.73-0.88-0.93-0.91-0.88-0.85-0.97-0.670.79
0.79-0.020.960.630.82-0.62-0.41-0.28-0.580.060.66-0.580.00.580.75-0.550.90.740.660.710.750.680.590.390.05
0.18-0.63-0.43-0.2-0.08-0.320.12-0.280.68-0.56-0.070.68-0.81-0.68-0.060.56-0.33-0.12-0.11-0.12-0.19-0.39-0.08-0.460.09
-0.44-0.48-0.72-0.81-0.69-0.010.76-0.580.68-0.33-0.761.0-0.56-1.0-0.710.91-0.76-0.76-0.73-0.76-0.75-0.87-0.73-0.770.45
-0.26-0.110.280.09-0.22-0.110.050.06-0.56-0.33-0.02-0.330.290.33-0.160.060.03-0.12-0.18-0.07-0.070.38-0.160.70.1
0.850.020.70.980.93-0.4-0.910.66-0.07-0.76-0.02-0.76-0.020.760.97-0.720.850.980.920.980.940.880.930.66-0.47
-0.44-0.48-0.72-0.81-0.69-0.010.76-0.580.681.0-0.33-0.76-0.56-1.0-0.710.91-0.76-0.76-0.73-0.77-0.75-0.87-0.73-0.770.45
-0.40.920.140.05-0.060.72-0.020.0-0.81-0.560.29-0.02-0.560.56-0.07-0.610.030.0-0.07-0.03-0.040.09-0.060.190.04
0.440.480.720.810.690.01-0.760.58-0.68-1.00.330.76-1.00.560.71-0.910.760.760.730.770.760.870.730.77-0.45
0.920.020.730.950.98-0.44-0.870.75-0.06-0.71-0.160.97-0.71-0.070.71-0.720.911.00.950.990.980.820.940.53-0.43
-0.45-0.69-0.61-0.73-0.73-0.190.71-0.550.560.910.06-0.720.91-0.61-0.91-0.72-0.71-0.76-0.73-0.74-0.73-0.66-0.73-0.450.41
0.870.040.90.860.94-0.52-0.730.9-0.33-0.760.030.85-0.760.030.760.91-0.710.920.890.910.950.860.840.57-0.34
0.890.070.740.960.98-0.4-0.880.74-0.12-0.76-0.120.98-0.760.00.761.0-0.760.920.960.990.980.850.940.57-0.45
0.870.050.650.910.94-0.39-0.930.66-0.11-0.73-0.180.92-0.73-0.070.730.95-0.730.890.960.970.970.840.990.53-0.65
0.890.030.730.980.96-0.42-0.910.71-0.12-0.76-0.070.98-0.77-0.030.770.99-0.740.910.990.970.990.880.960.63-0.52
0.890.030.750.950.96-0.45-0.880.75-0.19-0.75-0.070.94-0.75-0.040.760.98-0.730.950.980.970.990.870.950.59-0.51
0.69-0.010.790.920.78-0.44-0.850.68-0.39-0.870.380.88-0.870.090.870.82-0.660.860.850.840.880.870.850.89-0.52
0.840.050.60.920.91-0.34-0.970.59-0.08-0.73-0.160.93-0.73-0.060.730.94-0.730.840.940.990.960.950.850.57-0.7
0.35-0.050.590.740.44-0.29-0.670.39-0.46-0.770.70.66-0.770.190.770.53-0.450.570.570.530.630.590.890.57-0.42
-0.31-0.080.0-0.51-0.37-0.050.790.050.090.450.1-0.470.450.04-0.45-0.430.41-0.34-0.45-0.65-0.52-0.51-0.52-0.7-0.42
Click cells to compare fundamentals

Nautilus Biotechnology Account Relationship Matchups

Nautilus Biotechnology fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets18.5M85.0M398.5M350.1M305.6M239.0M
Short Long Term Debt Total275M4.8M30.0M30.3M34.6M50.6M
Other Current Liab201K1.1M2.1M1.5M407K386.7K
Total Current Liabilities490K3.0M5.8M6.8M9.1M4.6M
Total Stockholder Equity18.1M(29.7M)363.6M314.9M265.4M171.8M
Net Debt274.4M(31.8M)(155.6M)(84.2M)15.2M16.0M
Retained Earnings(14.7M)(30.3M)(80.6M)(138.6M)(202.2M)(192.1M)
Cash595K36.6M185.6M114.5M19.4M18.4M
Non Current Assets Total1.6M7.4M49.2M162.8M128.7M90.6M
Cash And Short Term Investments16.7M76.7M345.7M184.5M173.4M164.7M
Short Term Investments16.1M40.1M160.1M69.9M154.0M146.3M
Liabilities And Stockholders Equity18.5M85.0M398.5M350.1M305.6M239.0M
Non Current Liabilities Total275M111.7M29.1M28.3M31.1M29.5M
Other Current Assets305K303.8K7.0M2.7M3.4M3.6M
Other Stockholder Equity189K600K444.4M455.3M467.8M251.7M
Total Liab490K114.7M34.9M35.1M40.2M48.8M
Total Current Assets17.0M77.7M349.2M187.2M176.8M148.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Nautilus Stock Analysis

When running Nautilus Biotechnology's price analysis, check to measure Nautilus Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nautilus Biotechnology is operating at the current time. Most of Nautilus Biotechnology's value examination focuses on studying past and present price action to predict the probability of Nautilus Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nautilus Biotechnology's price. Additionally, you may evaluate how the addition of Nautilus Biotechnology to your portfolios can decrease your overall portfolio volatility.